STUDY REGARDING PAIN RELIEF IN POSTOPERATIVE MINIMAL INVASIVE SURGERY FOR KIDNEY REMOVAL FOR KIDNEY TRANSPLANTATION FOLLOWING INTRAPERITONEAL NEBULIZATION AND INTRAPERITONEAL INSTILLATION OF ROPIVACAINE
Phase 4
Completed
- Conditions
- Health Condition 1: null- ASA-I and II
- Registration Number
- CTRI/2014/08/004926
- Lead Sponsor
- SGPGIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
ASA-I-II
Scheduled for laparoscopic Nephrectomy
Free from pain in preoperative period
Not using analgesic drugs before surgery
Without cognitive impairment or mental retardation
written informed consent
Exclusion Criteria
Patient under 18 or over 65 years
ASA III,IV or V
Emergency or urgency surgery
Postoperative admission in an intesive care unit
Severe hepatic or renal impairment
Pregnancy or lactation
Allergy to one of the specific drugs under study
Alcohol or drug addiction
Acute infection or chronic disease
Progressive degenerative disease of CNS
Seizures or chronic therapy with antiepileptic drugs
Cognitive impairment or mental retardation
Any type of communication problem
No written informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative painTimepoint: In PACU, At 6 hr,at 24 hr,at 48 hr and at the time of discharge
- Secondary Outcome Measures
Name Time Method Hospital morbidityTimepoint: Intraoperative and Postoperative;Hospital stayTimepoint: Time in hours elapsed between surgery and hospital discharge;Postoperative Fentanyl requirementTimepoint: In PACU,At 6 hr,at 24 hr,48 hr,at the time of discharge;Quality of life after surgeryTimepoint: 4 weeks after surgery;Time of Unassisted walkingTimepoint: Time in hours between PACU discharge and when the patient able to walk